+ 33 1 46 99 68 20

Safeguarding essential medicines

DELBERT PHARMA’S VISION IS TO SAVE ESSENTIAL MEDECINES that have been abandoned by the pharmaceutical industry and are therefore doomed to disappear.


DELBERT Pharma ensures continuity of treatment for patients in critical need, especially when there are no therapeutic alternatives.

DELBERT Pharma’s business model enables us to maintain the availability of a pharmaceutical heritage made up of critical older drugs, thus avoiding loss of opportunity for many patients. DELBERT Pharma also works to relocate production in Europe, preserving exceptional technical know-how.

DELBERT Pharma

Our ambition

Protecting our pharmaceutical heritage by preserving patient access to essential medicines often lacking therapeutic alternatives

We work every day to:

SAFEGUARD essential medicines that meet critical patient needs,

 

 

 

RELOCATE the production of our medicines back to Europe as soon as possible.

ENSURE access for all patients in Europe and around the world.

 

These skills have enabled DELBERT Pharma to obtain the status
of a mission-driven company in September 2023.

DELBERT Pharma mobilizes collective thinking around a meaningful cause

The strength of the DELBERT Pharma project lies in its ability to integrate all players in the value chain to safeguard critical medicines which are at risk of disappearing:

=

The hospital physicians and pharmacists who believe in the value of mature molecules and have mastered these treatments.

=

The patients who are alerting us to their unmet needs and the loss of opportunity caused by the disappearance of non-substitutable treatments.

=

French and European manufacturers, some of whose available production capacity is no longer being used, despite their well-known pharmaceutical excellence.

=

The health authorities who are forced to fear shortages resulting from economic choices, rather than from therapeutic decisions taken with public health in mind.

=

The financial institutions who believe in the value of this developing model and are committed to supporting it over the long term.

Our expertise

a unique know-how

Making relocation of production and quality our priorities

Every time DELBERT Pharma buys a molecule :

  • the company assesses the possibility of repatriate production to France or Europe, integrates European standards in terms of good manufacturing practices, invests in equipment to relaunch production locally,
  • this unique model also owes its originality to mastery of every stage in the value chain The integration of inventory management, logistics, regulatory affairs and quality,
  • an approach based on specific technical expertise in injectable drugs, antibiotic therapy and small-volume production.

Ensure market access and distribution to as many patients as possible

  • We work closely with local health authorities at every stage of the project.
  • We are committed to making our medicines available to all patients who need them, particularly in Europe, by expanding our direct sales or through international partnerships.

Expanding our portfolio of medications

  • We continually take into account the needs of healthcare professionals when setting our priorities.
  • We identify essential medications that are at risk of being discontinued but for which there is still a need.

Foster our entrepreneurial spirit

Our agility is based on a willingness to act and entrepreneurial freedom.
We encourage our employees’ individual initiatives for personal fulfillment and to serve the collective interest, in the service of patients and healthcare professionals.
This entrepreneurial spirit enables us toattract talent in search of meaning and adventure, both in France and abroad.

Our values

5 values guide our decisions, drive us and unite us around our mission on a daily basis

A duty to the patients

Because we are in solidarity with patients suffering from the disappearance of essential medicines, we have decided to rehabilitate these treatments and are investing all our profits in their development.

We need courage and determination to succeed and to remanufacture in Europe and especially in France… we are taking on our responsibilities.

The expertise of a calling

We share the same ambition: to bring together skills and strengthen cooperation. A team effort to provide lasting solutions to meet medical needs.

The uniqueness of our practices

We put all our determination into expressing our differences to find original and agile solutions to serve patients.

Honouring our commitments

Confident in our ability to save medicines, we are ethically driven not to neglect any patient.

Pleasure every day

We are a company on a human scale that works in good humor to integrate and develop each of its employees so that they can blossom within the company.

Our therapeutic areas

Infectiology

Neurology

Other

REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT

To request medical information on DELBERT Pharma products or report an adverse event,

please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.